Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

Abstract

Hyperphosphorylation of microtubule-associated proteins such as tau and neurofilament may underlie the cytoskeletal abnormalities and neuronal death seen in several neurodegenerative diseases including Alzheimer's disease. One potential mechanism of microtubule-associated protein hyperphosphorylation is augmented activity of protein kinases known to associate with microtubules, such as cdk5 or GSK3␤. Here we show that tau and neurofilament are hyperphosphorylated in transgenic mice that overexpress human p25, an activator of cdk5. The p25 transgenic mice display silver-positive neurons using the Bielschowsky stain. Disturbances in neuronal cytoskeletal organization are apparent at the ultrastructural level. These changes are localized predominantly to the amygdala, thalamus͞hypothalamus, and cortex. The p25 transgenic mice display increased spontaneous locomotor activity and differences from control in the elevated plus-maze test. The overexpression of an activator of cdk5 in transgenic mice results in increased cdk5 activity that is sufficient to produce hyperphosphorylation of tau and neurofilament as well as cytoskeletal disruptions reminiscent of Alzheimer's disease and other neurodegenerative diseases. Although many protein kinases phosphorylate tau at ADrelevant epitopes in vitro (reviewed in ref.2), only two have been copurified with microtubules, GSK3␤ and cdk5 (3, 4). To our knowledge, only these two kinases will phosphorylate tau in a cellular environment (e.g., refs. 5 and 6). We chose to focus on cdk5 because it is active predominantly in neurons whereas GSK3␤ plays a role in energy metabolism and is active in all cells. cdk5 is a member of the cyclin-dependent protein kinase gene family. Rather than cyclins, cdk5 associates with the positive allosteric regulators p35 (7), amino-terminal proteolytic fragments of p35 (e.g., p25; ref. 8), and p39 (9). These proteins share minimal amino acid sequence homology to cyclins, but the mechanism of activation of cdk5 by p25͞35 may be similar to the activation of cdk2 by cyclin A (10). p25͞35 is expressed predominantly in neurons, implying that most cdk5 activity is concentrated in neuronal structures (7,8). cdk5 plays a pivotal role in neuronal development as evidenced by the abnormal corticogenesis and perinatal lethality of cdk5 knockout mice (11) and the disturbances in neuronal migration and early death in p35 knockout mice (12). A number of potential cdk5 substrates have been identified and most are consistent with a putative role in neurite outgrowth and plasma membrane dynamics. These include cytoskeletal proteins such as tau and neurofilament (e.g., refs. 13 and 14) and synaptic vesicle proteins (15, 16). To clarify the potential role of cdk5 in neurodegenerative diseases in vivo, we overexpressed human p25 in the brains of transgenic mice to determine whether increased cdk5 activity would lead to hyperphosphorylation of tau and neurofilament and͞or cytoskeletal disturbances. Materials and MethodsAnimal Handling. All experimentation was performed under...

CDK5 Knockdown Prevents Hippocampal Degeneration and Cognitive Dysfunction Produced by Cerebral Ischemia

“…These results are very suggestive because calpain and p25 are necessary elements for CDK5 catalytic activation both in vitro and in vivo. 28 The CDK5miR treatment protected the cerebral cortex from neurodegenerative events despite not being directly transduced into that ischemic tissue. This result was demonstrated by (1) sensorimotor score improvements during the first week after ischemia and (2) a significant reduction of the infarct volume and a decrease of CDK5 protein levels in the cerebral cortex and hippocampus 6 days after ischemia.…”

Senescence-Accelerated Mice P8: A Tool to Study Brain Aging and Alzheimer's Disease in a Mouse Model

“…In the case of AD, the models used are mice that are genetically modified by human gene insertions with the main proteins associated with AD, that is, protein beta amyloid precursor (APP) and tau protein. We also have models in which tau kinases are overexpressed, including cyclindependent kinase 5 (cdk5) [7] or glycogen synthase kinase 3 β (GSK3β) [8]. However, none of the numerous animal models reliably reflect what occurs in humans.…”

Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase

“…Many kinases may be involved in tau phosphorylation in vitro and in vivo (42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53), including glycogen synthase kinase-3␤ (GSK-3␤), cyclin-dependent kinase-5 (Cdk-5) and its activators, the phosphorylated (active) form of extracellular signal-regulated kinase (p-Erk), microtubule-affinity regulating kinase, and fyn kinase. Zinc, which is highly concentrated in synaptic vesicles in the mossy fiber zone of the hippocampus and may also be involved in AD pathogenesis (54), can activate some of these kinases, including Erk (55)(56)(57)(58)(59)(60)(61)(62).…”